Financials

  • Market Capitalization 381.73 M
  • Employee 55
  • Founded 2012
  • CEO N/A
  • Website www.ateapharma.com
  • Headquarter Massachusetts, United States
  • FIGI BBG00TZNCJ75
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.84
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3121
LRMR
Larimar Therapeutics, Inc. - Common Stock
3.73 USD0.00%+13.37%+6.27%+6.27%387.48 M USD
3129
XFOR
X4 Pharmaceuticals, Inc. - Common Stock
4.03 USD-0.49%+1.00%-1.23%+35.69%380.11 M USD
3147
FENC
Fennec Pharmaceuticals Inc. - Common Stock
10.71 USD-0.37%+0.66%+18.34%+21.02%372.03 M USD
3166
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.65 USD0.00%0.00%+2.65%+3.33%365.13 M USD

Noticias